| Prev Close | 1.70 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 1.08 / 4.67 |
Verastem, Inc. (VSTM)
1.70
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 169.77B |
| Market Cap | 288.62M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Verastem Could Be Purchased After a Test of the 200-Day Average Line
Verastem could be a buy after a test of the 200-day line around $5.50.
Names to Watch Amid Biotech's Nascent Rally
Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.
3 Busted IPOs with 10-Bagger Potential
Verastem Inc., T2 Biosystems Inc. and Resonant Inc. have great long-term growth prospects.
These Biotechs Are Movers Today
The market is down across the board as one might expect given escalating trade tensions today. However, losses are slight in this context in the first hour of trading. Given the option expiration date, volatility could pick up later in the day. Some...
Could These 2 Biotech 'Busted IPOs' Be the Next Ignyta?
After Roche's acquisition of Ignyta, I have high hopes for these other two names in 2018.
2 Biotech 'Busted IPOs' to Watch in 2018
Are these names the next 'Ignytas'?
3 Small Biotech Stocks Insiders Are Buying
Verastem Inc., Pieris Pharmaceuticals and Intra-Cellular Therapies all have promising products.
Sizing Up Some Small-Cap Stocks
Consistent insider buying can provide clues.
